Jade Biosciences, Inc.
JBIO · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $341,614 | $284,027 | $72,752 | $76,810 |
| - Cash | $50,106 | $220,942 | $44,220 | $33,751 |
| + Debt | $747 | $792 | $312 | $417 |
| Enterprise Value | $292,255 | $63,877 | $28,844 | $43,476 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | -$12 | -$1 | -$4 | -$8 |
| % Margin | – | – | – | – |
| EBITDA | -$25,163 | -$32,133 | -$2,514 | -$5,367 |
| % Margin | – | – | – | – |
| Net Income | -$25,175 | -$32,134 | -$2,518 | -$5,430 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.64 | -1.13 | -3.04 | -6.557 |
| % Growth | 43.4% | 62.8% | 53.6% | – |
| Operating Cash Flow | -$22,124 | -$36,535 | – | -$11,047 |
| Capital Expenditures | -$57 | -$136 | – | $0 |
| Free Cash Flow | -$22,181 | -$36,671 | – | -$11,047 |